To Battle The Opioid Overdose Epidemic, Deploy The ‘Cascade of Care’ Model

Despite a plateau in opioid prescribing, opioid-related overdose deaths have continued to climb in epidemic proportion. Much of the recent rise is related to unpredictable adulteration of heroin and black market pills with fentanyl and other potent synthetics. However the death rate also reflects longstanding treatment gaps; a majority of the 2.4 million individuals in the United States with an opioid use disorder do not receive evidence based medication-assisted treatment (MAT) with methadone, buprenorphine, or long-acting injectable naltrexone.